Tesla: Now That's More Like It
Tesla: Now That's More Like It
China's CBIRC quietly made a big correction in Tesla's August MY insured sales which eliminated the huge discrepancy between results previously reported by CATARC and sales numbers from CPCA.
CATARC data for insured August sales was recently amended by CBIRC to indicate MY sales actually closely tracked reported sales by CPCA—which is more typical with long term trends.
As such, the copy below updates and has been added to my previous report Tesla's August Sales Numbers in China Don't Add Up published on 9/17/21 to reflect the corrected numbers from CBIRC versus the grossly incorrect data previously reported by CATARC.
Well, That’s Completely Different
China Automotive Technology and Research Center CATARC tracks insurance registrations rather than sales data provided by carmakers as collected by CPCA. This tends to align closely with monthly retail sales since cars must be insured before they can be licensed. Tesla sales are all cash due upon delivery, so insurance must be arranged and finalized before the customer can take possession of the car.
CATARC is regulated by China Banking & Insurance Regulatory Commission (CBIRC).
Important data from CBIRC was recently released since my report Tesla's August Sales Numbers in China Don't Add Up was published on 9/17/21 which corrected an extreme and highly unusual difference between reported August sales by CPCA and insured sales reported by CATARC.
CBIRC reported, without further clarification, that indicated Model Y insured sales were 11,721 in August—well within the more traditionally slim margin versus CPCA reported sales at 11,576.
This corrected a dramatically lower 1,538 for Model Y, down 28% versus weak July results, which previously had been reported by CATARC and which had created a stunning 10,038 difference versus the 11,576 previously reported by CPCA.
As such, my related report has been edited to reflect the corrected numbers from CBIRC and delete grossly incorrect data as originally reported by CATARC.
CBIRC reported Model 3 insured August sales at 1,273, confirming previously reported results by CATARC which had closely aligned with the weak 1,309 (down a whopping 89% y/y) as reported by CPCA.
CBIRC’s action to correct the large discrepancy in reported August Model Y sales was no doubt a great relief to Tesla, which has enough trouble with regulators already in China as well as the US—not to mention its voracious local rivals which are rapidly absorbing market share.
Stay tuned.
Contact Us:
Disclaimer
This publication is prepared by Bond Angle LLC and is distributed solely to authorized recipients and clients of Bond Angle for their general use. In addition:
I/We have no position(s) in any of the securities referenced in this publication.
Views expressed in this publication accurately reflects my/our personal opinion(s) about the referenced securities and issuers and/or other subject matter as appropriate.
This publication does not contain and is not based on any non-public, material information.
To the best of my/our knowledge, the views expressed in this publication comply with applicable law in the country from which it is posted.
I/We have not been commissioned to write this publication or hold any specific opinion on the securities referenced therein.
Bond Angle does not do business with companies covered in its
publications, and nothing in this publication should be construed as a solicitation to buy or sell any security or product.Bond Angle accepts no liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this publication and/or further communication in relation to this document.